Showing results (1-10 of 709) with videos related to

Sort By:
Pageof 71
The Lancet. Haematology|January 22, 2021
Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort studyAkshay Sharma, Neel S Bhatt, Andrew St Martin, et al.
The Lancet. Haematology|January 28, 2021
Proposed global prognostic score for systemic mastocytosis: a retrospective prognostic modelling studyJavier I Muñoz-González, Iván Álvarez-Twose, María Jara-Acevedo, et al.
The Lancet. Haematology|January 29, 2021
Preservation of fertility in teenagers and young adults treated for haematological malignanciesEphia Yasmin, Rod Mitchell, Sheila Lane
The Lancet. Haematology|December 10, 2021
Management of drug-drug interactions of targeted therapies for haematological malignancies and triazole antifungal drugsRoger J Brüggemann, Rebecca Verheggen, Emmy Boerrigter, et al.
The Lancet. Haematology|December 31, 2021
Efficacy and safety of itacitinib versus placebo in combination with corticosteroids for initial treatment of acute graft-versus-host disease (GRAVITAS-301): a randomised, multicentre, double-blind, phase 3 trialRobert Zeiser, Gérard Socié, Mark A Schroeder, et al.
The Lancet. Haematology|December 31, 2021
Hydroxyurea for primary stroke prevention in children with sickle cell anaemia in Nigeria (SPRING): a double-blind, multicentre, randomised, phase 3 trialShehu U Abdullahi, Binta W Jibir, Halima Bello-Manga, et al.
The Lancet. Haematology|December 31, 2021
Survival by age in paediatric and adolescent patients with Hodgkin lymphoma: a retrospective pooled analysis of children's oncology group trialsJustine M Kahn, Qinglin Pei, Debra L Friedman, et al.
The Lancet. Haematology|June 19, 2019
Ibrutinib plus fludarabine, cyclophosphamide, and rituximab as initial treatment for younger patients with chronic lymphocytic leukaemia: a single-arm, multicentre, phase 2 trialMatthew S Davids, Danielle M Brander, Haesook T Kim, et al.
The Lancet. Haematology|October 8, 2021
A comprehensive approach to therapy of haematological malignancies in older patientsRaul Cordoba, Toby A Eyre, Heidi D Klepin, et al.
The Lancet. Haematology|March 31, 2022
In-vivo T-cell depleted reduced-intensity conditioned allogeneic haematopoietic stem-cell transplantation for patients with acute lymphoblastic leukaemia in first remission: results from the prospective, single-arm evaluation of the UKALL14 trialDavid I Marks, Laura Clifton-Hadley, Mhairi Copland, et al.
Pageof 71